BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 20514639)

  • 21. The involvement of the ubiquitin system in Alzheimer's disease (review).
    Pallares-Trujillo J; Lopez-Soriano FJ; Argilés JM
    Int J Mol Med; 1998 Jul; 2(1):3-15. PubMed ID: 9854137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transient intraneuronal A beta rather than extracellular plaque pathology correlates with neuron loss in the frontal cortex of APP/PS1KI mice.
    Christensen DZ; Kraus SL; Flohr A; Cotel MC; Wirths O; Bayer TA
    Acta Neuropathol; 2008 Dec; 116(6):647-55. PubMed ID: 18974993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Tau, amyloid and Alzheimer's disease].
    Olesen OF
    Ugeskr Laeger; 1994 Feb; 156(8):1116-7, 1121-4. PubMed ID: 8116089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biochemical and anatomical redistribution of tau protein in Alzheimer's disease.
    Mukaetova-Ladinska EB; Harrington CR; Roth M; Wischik CM
    Am J Pathol; 1993 Aug; 143(2):565-78. PubMed ID: 8342603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alzheimer's disease: Abeta, tau and synaptic dysfunction.
    LaFerla FM; Oddo S
    Trends Mol Med; 2005 Apr; 11(4):170-6. PubMed ID: 15823755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insights from Drosophila models of Alzheimer's disease.
    Cowan CM; Shepherd D; Mudher A
    Biochem Soc Trans; 2010 Aug; 38(4):988-92. PubMed ID: 20658990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Alzheimer's disease: lesions and their progression].
    Duyckaerts C; Colle MA; Delatour B; Hauw JJ
    Rev Neurol (Paris); 1999; 155 Suppl 4():S17-27. PubMed ID: 10637934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biomedicine. Tauists and beta-aptists united--well almost!
    Lee VM
    Science; 2001 Aug; 293(5534):1446-7. PubMed ID: 11520974
    [No Abstract]   [Full Text] [Related]  

  • 29. [Neurofibrillary tangles and early modification of the neuronal cytoskeleton in Alzheimer's disease and in experimental models].
    Brion JP
    Bull Mem Acad R Med Belg; 1999; 154(6 Pt 2):287-94. PubMed ID: 10992876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alzheimer's mechanisms in ischemic brain degeneration.
    Pluta R; Ułamek M; Jabłoński M
    Anat Rec (Hoboken); 2009 Dec; 292(12):1863-81. PubMed ID: 19943340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuropathology and the neuroinflammation idea.
    Mrak RE
    J Alzheimers Dis; 2009; 18(3):473-81. PubMed ID: 19584454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Seminars in medicine of the Beth Israel Hospital, Boston. beta-Amyloid and the pathogenesis of Alzheimer's disease.
    Yankner BA; Mesulam MM
    N Engl J Med; 1991 Dec; 325(26):1849-57. PubMed ID: 1961223
    [No Abstract]   [Full Text] [Related]  

  • 33. Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease.
    Barage SH; Sonawane KD
    Neuropeptides; 2015 Aug; 52():1-18. PubMed ID: 26149638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Molecular actors in Alzheimer's disease: which diagnostic and therapeutic consequences?].
    Buée L; Blum D; Bombois S; Buée-Scherrer V; Caillet-Boudin ML; Colin M; Deramecourt V; Dhaenens CM; Galas MC; Hamdane M; Humez S; Maurage CA; Pasquier F; Sablonnière B; Schraen-Maschke S; Sergeant N
    Therapie; 2010; 65(5):401-7. PubMed ID: 21144474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amyloid-beta, tau protein, and oxidative changes as a physiological compensatory mechanism to maintain CNS plasticity under Alzheimer's disease and other neurodegenerative conditions.
    Koudinov A; Kezlya E; Koudinova N; Berezov T
    J Alzheimers Dis; 2009; 18(2):381-400. PubMed ID: 19749430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of tau phosphorylation and protection against beta-amyloid-induced neurodegeneration by lithium. Possible implications for Alzheimer's disease.
    Alvarez G; Muñoz-Montaño JR; Satrústegui J; Avila J; Bogónez E; Díaz-Nido J
    Bipolar Disord; 2002 Jun; 4(3):153-65. PubMed ID: 12180271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of β-amyloid peptide in neurodegenerative diseases.
    Maltsev AV; Bystryak S; Galzitskaya OV
    Ageing Res Rev; 2011 Sep; 10(4):440-52. PubMed ID: 21406255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Roles of p75NTR in the pathogenesis of Alzheimer's disease: a novel therapeutic target.
    Zeng F; Lu JJ; Zhou XF; Wang YJ
    Biochem Pharmacol; 2011 Nov; 82(10):1500-9. PubMed ID: 21762680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autophagy in Alzheimer's disease.
    Moreira PI; Santos RX; Zhu X; Lee HG; Smith MA; Casadesus G; Perry G
    Expert Rev Neurother; 2010 Jul; 10(7):1209-18. PubMed ID: 20586699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Towards development of drugs targeting both amyloid and tau pathologies of Alzheimer's disease.
    Shin J
    Int J Geriatr Psychiatry; 2011 May; 26(5):546-8. PubMed ID: 21446001
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.